{"transactions":[{"id":707442,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T12:32:05.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2026, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.68,"expiration_date":"2036-07-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-084437","document":"tm2620629-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926084437/tm2620629-4_4seq1.xml","form_type":"4"}},{"id":743184,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-10T21:26:36.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":8.7,"value":217500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 10, 2026, Khalid Islam was granted a non-qualified stock option to purchase 25,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on date of grant."}],"balance_after":250000,"derivative":{"exercise_price":8.7,"exercise_date":"2026-06-10","expiration_date":"2036-06-10","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001701858-26-000002","document":"form4-06102026_090631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000170185826000002/form4-06102026_090631.xml","form_type":"4"}},{"id":1101989,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-25T21:30:23.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001641172-25-016541","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000164117225016541/ownership.xml","form_type":"4"}},{"id":1122948,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-04T20:20:07.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":7.88,"value":197000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 3, 2025, Khalid Islam was granted a non-qualified stock option to purchase 25,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on date of grant."}],"balance_after":225000,"derivative":{"exercise_price":7.88,"exercise_date":"2025-06-03","expiration_date":"2035-06-03","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-25-015586","document":"form4-06042025_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000141588925015586/form4-06042025_040601.xml","form_type":"4"}},{"id":1429393,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-08-19T23:02:15.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":5.58,"value":139500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 15, 2024, Khalid Islam was granted a non-qualified stock option to purchase 25,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested of date of grant."}],"balance_after":200000,"derivative":{"exercise_price":5.58,"exercise_date":"2024-08-15","expiration_date":"2034-08-15","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-24-021641","document":"form4-08192024_110810.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000141588924021641/form4-08192024_110810.xml","form_type":"4"}},{"id":1436327,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-08-12T21:23:30.000Z","date":"2024-08-09","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.9988,"value":49940.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.9814 to $1.00 per share, inclusive. The reporting person undertakes to provide to Gain Therapeutics, Inc., any security holder of Gain Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001493152-24-031377","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224031377/ownership.xml","form_type":"4"}},{"id":1469121,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-27T01:30:12.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.29,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-24-025342","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224025342/ownership.xml","form_type":"4"}},{"id":1739111,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-11-16T21:05:27.000Z","date":"2023-11-16","kind":"exercise","planned":false,"acquired":false,"shares":20492,"price":2.44,"value":50000.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"Represents options granted on June 9, 2016, with a strike price of $2.44 and an expiration date of June 9, 2026."}],"balance_after":175000,"derivative":{"exercise_price":2.44,"exercise_date":"2016-06-09","expiration_date":"2026-06-09","underlying":"Options","underlying_shares":20492},"source":{"system":"sec-edgar","filing":"0001415889-23-015193","document":"form4-11162023_091111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000141588923015193/form4-11162023_091111.xml","form_type":"4"}},{"id":1739110,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-11-16T21:05:27.000Z","date":"2023-11-16","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":1.13,"value":56500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Represents options granted on December 11, 2015, with a strike price of $1.13 and an expiration date of December 11, 2025."}],"balance_after":195492,"derivative":{"exercise_price":1.13,"exercise_date":"2015-12-11","expiration_date":"2025-12-11","underlying":"Options","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-23-015193","document":"form4-11162023_091111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000141588923015193/form4-11162023_091111.xml","form_type":"4"}},{"id":1739109,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-11-16T21:05:27.000Z","date":"2023-11-16","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":2.69,"value":26900.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Represents options granted on December 31, 2014, with a strike price of $2.69 and an expiration date of December 31, 2024."}],"balance_after":245492,"derivative":{"exercise_price":2.69,"exercise_date":"2014-12-31","expiration_date":"2024-12-31","underlying":"Options","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-23-015193","document":"form4-11162023_091111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000141588923015193/form4-11162023_091111.xml","form_type":"4"}},{"id":1739108,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-11-16T21:05:27.000Z","date":"2023-11-16","kind":"exercise","planned":false,"acquired":false,"shares":133333,"price":2.31,"value":307999.23,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents options granted on April 25, 2014, with a strike price of $2.31 and an expiration date of April 25, 2024."}],"balance_after":255492,"derivative":{"exercise_price":2.31,"exercise_date":"2014-04-25","expiration_date":"2024-04-25","underlying":"Options","underlying_shares":133333},"source":{"system":"sec-edgar","filing":"0001415889-23-015193","document":"form4-11162023_091111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000141588923015193/form4-11162023_091111.xml","form_type":"4"}},{"id":1739107,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-11-16T21:05:27.000Z","date":"2023-11-16","kind":"exercise","planned":false,"acquired":true,"shares":20492,"price":2.44,"value":50000.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Shares acquired through the exercise of an option contract with a strike of $2.44 and an expiration date of June 9, 2026."}],"balance_after":213825,"source":{"system":"sec-edgar","filing":"0001415889-23-015193","document":"form4-11162023_091111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000141588923015193/form4-11162023_091111.xml","form_type":"4"}},{"id":1739106,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-11-16T21:05:27.000Z","date":"2023-11-16","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":1.13,"value":56500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares acquired through the exercise of an option contract with a strike of $1.13 and an expiration date of December 11, 2025."}],"balance_after":193333,"source":{"system":"sec-edgar","filing":"0001415889-23-015193","document":"form4-11162023_091111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000141588923015193/form4-11162023_091111.xml","form_type":"4"}},{"id":1739105,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-11-16T21:05:27.000Z","date":"2023-11-16","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":2.69,"value":26900.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired through the exercise of an option contract with a strike of $2.69 and an expiration date of December 31, 2024."}],"balance_after":143333,"source":{"system":"sec-edgar","filing":"0001415889-23-015193","document":"form4-11162023_091111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000141588923015193/form4-11162023_091111.xml","form_type":"4"}},{"id":1739104,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-11-16T21:05:27.000Z","date":"2023-11-16","kind":"exercise","planned":false,"acquired":true,"shares":133333,"price":2.31,"value":307999.23,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with a strike of $2.31 and an expiration date of April 25, 2024."}],"balance_after":133333,"source":{"system":"sec-edgar","filing":"0001415889-23-015193","document":"form4-11162023_091111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000141588923015193/form4-11162023_091111.xml","form_type":"4"}},{"id":1844593,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T20:40:01.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":10500,"derivative":{"exercise_price":4.5,"expiration_date":"2033-06-23","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-23-039726","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123039726/doc4.xml","form_type":"4"}},{"id":1857266,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-06-13T16:39:51.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 12, 2023, Khalid Islam was granted a non-qualified stock option to purchase 25,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested of date of grant."}],"balance_after":388825,"derivative":{"exercise_price":8.78,"exercise_date":"2023-06-12","expiration_date":"2033-06-12","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-23-009706","document":"form4-06132023_040647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000141588923009706/form4-06132023_040647.xml","form_type":"4"}},{"id":2152994,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-22T20:13:28.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests fully on the day before the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":10500,"derivative":{"exercise_price":3.5,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-22-051012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122051012/doc4.xml","form_type":"4"}},{"id":2230015,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T13:24:58.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 14, 2022, Khalid Islam was granted a non-qualified stock option to purchase 25,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":5.59,"expiration_date":"2032-06-14","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-22-071689","document":"tm2218610-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000110465922071689/tm2218610-4_4seq1.xml","form_type":"4"}},{"id":2294828,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2022-04-20T01:15:39.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":18208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock units vest 100% on December 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted stock units vest 100% on December 31, 2022."}],"balance_after":18208,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":18208},"source":{"system":"sec-edgar","filing":"0001567619-22-008682","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000156761922008682/doc1.xml","form_type":"4"}},{"id":2308389,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T21:57:30.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":4392,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of time-based restricted shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares previously reported as indirectly held by Elion Oncology were transferred to the reporting person's direct holdings in a transaction exempt from Section 16 reporting pursuant to Rule 16a-13."}],"balance_after":72486,"source":{"system":"sec-edgar","filing":"0001567619-22-008012","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000156761922008012/doc1.xml","form_type":"4"}},{"id":2647671,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-01T17:00:59.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 29, 2021, Khalid Islam was granted a non-qualified stock option to purchase 25,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":7.52,"expiration_date":"2031-06-29","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-21-088127","document":"tm2121155-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000110465921088127/tm2121155-4_4seq1.xml","form_type":"4"}},{"id":3001147,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-10-23T17:33:34.000Z","date":"2020-10-23","kind":"disposition_to_issuer","acquired":false,"shares":3718,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"In connection with the consummation of the Merger, at the Effective Time, each restricted stock unit to acquire shares of Common Stock (\"Restricted Stock Unit\") that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash equal to (A) the Offer Price, multiplied by (B) the total number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the consummation of the Merger, at the Effective Time, each restricted stock unit to acquire shares of Common Stock (\"Restricted Stock Unit\") that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash equal to (A) the Offer Price, multiplied by (B) the total number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In connection with the consummation of the Merger, at the Effective Time, each restricted stock unit to acquire shares of Common Stock (\"Restricted Stock Unit\") that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash equal to (A) the Offer Price, multiplied by (B) the total number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"In connection with the consummation of the Merger, at the Effective Time, each restricted stock unit to acquire shares of Common Stock (\"Restricted Stock Unit\") that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash equal to (A) the Offer Price, multiplied by (B) the total number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3718},"source":{"system":"sec-edgar","filing":"0001104659-20-117797","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920117797/a4.xml","form_type":"4"}},{"id":3001146,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-23T17:33:34.000Z","date":"2020-10-23","kind":"disposition_to_issuer","acquired":false,"shares":52614,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":52614},"source":{"system":"sec-edgar","filing":"0001104659-20-117797","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920117797/a4.xml","form_type":"4"}},{"id":3001145,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-23T17:33:34.000Z","date":"2020-10-23","kind":"disposition_to_issuer","acquired":false,"shares":13516,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.01 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was automatically cancelled and converted into the right to receive $88.00 in cash (the \"Offer Price\"), without interest and subject to required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.01 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was automatically cancelled and converted into the right to receive $88.00 in cash (the \"Offer Price\"), without interest and subject to required withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-117797","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920117797/a4.xml","form_type":"4"}},{"id":3057372,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-14T19:17:12.000Z","date":"2020-08-13","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 13, 2020, Khalid Islam was granted a non-qualified stock option to purchase 25,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":6.17,"expiration_date":"2030-08-13","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-095448","document":"tm2027709d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000110465920095448/tm2027709d4_4.xml","form_type":"4"}},{"id":3103712,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-22T17:20:07.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":6540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2020 annual meeting of stockholders, which occurred on June 18, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":6540,"derivative":{"exercise_price":33.62,"exercise_date":"2021-06-18","expiration_date":"2030-06-18","underlying":"Common Stock, par value $0.01 per share","underlying_shares":6540},"source":{"system":"sec-edgar","filing":"0001104659-20-075695","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920075695/a4.xml","form_type":"4"}},{"id":3103711,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value per share","published_at":"2020-06-22T17:20:07.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":3718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2020 annual meeting of stockholders, which occurred on June 18, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":17234,"source":{"system":"sec-edgar","filing":"0001104659-20-075695","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920075695/a4.xml","form_type":"4"}},{"id":3484287,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-20T00:33:42.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 18, 2019, Khalid Islam was granted an incentive stock option to purchase 25,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":4.26,"expiration_date":"2029-06-18","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001144204-19-031564","document":"tv523893_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000114420419031564/tv523893_4.xml","form_type":"4"}},{"id":3495044,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-11T16:32:45.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":17077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2019 annual meeting of stockholders, which occurred on June 7, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":17077,"derivative":{"exercise_price":12.93,"exercise_date":"2020-06-07","expiration_date":"2026-06-07","underlying":"Common Stock, par value $0.01 per share","underlying_shares":17077},"source":{"system":"sec-edgar","filing":"0001104659-19-034792","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919034792/a4.xml","form_type":"4"}},{"id":3495043,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value per share","published_at":"2019-06-11T16:32:45.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":9667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2019 annual meeting of stockholders, which occurred on June 7, 2019."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":13516,"source":{"system":"sec-edgar","filing":"0001104659-19-034792","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919034792/a4.xml","form_type":"4"}},{"id":3812177,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-09-19T15:21:15.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":6497,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2018 annual meeting of stockholders, which occurred on April 2, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":6497,"derivative":{"exercise_price":14.29,"exercise_date":"2019-04-02","expiration_date":"2025-04-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":6497},"source":{"system":"sec-edgar","filing":"0001171843-18-006626","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000117184318006626/ownership.xml","form_type":"4"}},{"id":3812176,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value per share","published_at":"2018-09-19T15:21:15.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":3849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2018 annual meeting of stockholders, which occurred on April 2, 2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":3849,"source":{"system":"sec-edgar","filing":"0001171843-18-006626","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000117184318006626/ownership.xml","form_type":"4"}},{"id":3898547,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-11T14:44:49.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 8, 2018, Khalid Islam was granted an incentive stock option to purchase 25,000 common shares of the Issuer pursuant to the Issuer's Amended and Restated Stock Option Plan.  The option is 100% vested on the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":10.93,"exercise_date":"2018-06-08","expiration_date":"2025-06-08","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001144204-18-033681","document":"tv496273_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000114420418033681/tv496273_4.xml","form_type":"4"}},{"id":4262916,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-07-06T18:01:41.000Z","date":"2017-07-03","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22500,"derivative":{"exercise_price":9.02,"exercise_date":"2018-07-03","expiration_date":"2024-07-03","underlying":"Common Stock, par value $0.01 per share","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001104659-17-043897","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465917043897/a4.xml","form_type":"4"}}]}